Spots Global Cancer Trial Database for radium ra 223 dichloride
Every month we try and update this database with for radium ra 223 dichloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis | NCT03317392 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Biopsy Biospecimen Col... Computed Tomogr... Laboratory Biom... Magnetic Resona... Olaparib Quality-of-Life... Radium Ra 223 D... | 18 Years - | National Cancer Institute (NCI) | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones | NCT04090398 | Anatomic Stage ... Metastatic HER2... Metastatic Mali... | Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones | NCT04090398 | Anatomic Stage ... Metastatic HER2... Metastatic Mali... | Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E... | 18 Years - | National Cancer Institute (NCI) | |
| Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis | NCT02507570 | Prostate Carcin... | Enzalutamide Radium ra 223 d... | 18 Years - | Carolina Research Professionals, LLC | |
| Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) | NCT03076203 | Prostate Carcin... Stage IV Prosta... Hormone-refract... | Niraparib Radium Ra 223 D... | 18 Years - | Thomas Jefferson University | |
| Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer | NCT03344211 | Castration-Resi... Prostate Carcin... Stage IV Prosta... | Enzalutamide Laboratory Biom... Radium Ra 223 D... | 18 Years - | University of Southern California | |
| Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy | NCT04071236 | Castration-Resi... Metastatic Mali... Metastatic Pros... Stage IV Prosta... | Avelumab Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Peposertib Questionnaire A... Radium Ra 223 D... | 18 Years - | National Cancer Institute (NCI) | |
| Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer | NCT02199197 | Prostate Cancer | Radium Ra 223 D... Enzalutamide | 18 Years - | University of Utah | |
| Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer | NCT02199197 | Prostate Cancer | Radium Ra 223 D... Enzalutamide | 18 Years - | University of Utah | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis | NCT02507570 | Prostate Carcin... | Enzalutamide Radium ra 223 d... | 18 Years - | Carolina Research Professionals, LLC | |
| Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis | NCT02507570 | Prostate Carcin... | Enzalutamide Radium ra 223 d... | 18 Years - | Carolina Research Professionals, LLC | |
| Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) | NCT03076203 | Prostate Carcin... Stage IV Prosta... Hormone-refract... | Niraparib Radium Ra 223 D... | 18 Years - | Thomas Jefferson University | |
| Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study | NCT04071223 | Advanced Renal ... Chromophobe Ren... Clear Cell Rena... Collecting Duct... Kidney Medullar... Metastatic Mali... Papillary Renal... Stage IV Renal ... Unclassified Re... | Cabozantinib S-... Quality-of-Life... Questionnaire A... Radium Ra 223 D... | 18 Years - | National Cancer Institute (NCI) | |
| Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone | NCT03304418 | Prostate Cancer... | Radium Ra 223 D... Radiation | 18 Years - | University of Utah |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
